Outcomes and Prognostic Factors of Acute Mastoiditis in the Grand-Est Region
MAGE
Évaluation Des Facteurs Pronostiques et de l'évolution Des mastoïdites aigües Dans la région Grand-Est
1 other identifier
observational
326
1 country
1
Brief Summary
There is an increased incidence of acute mastoïditis and a lack of homogeneity in management. The investigator aim to refine the epidemiological knowledge on this pathology. Data of children with acute mastoiditis of the last ten years in five hospitals of the North-East of France (University Hospitals of Nancy, Strasbourg, Dijon, Besançon and the Regional Hospital of Metz-Thionville) will be analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 3, 2024
CompletedStudy Start
First participant enrolled
March 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2025
CompletedFirst Posted
Study publicly available on registry
August 14, 2025
CompletedAugust 14, 2025
August 1, 2025
1.4 years
January 3, 2024
August 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prognostic factors of recovery in children hospitalized for mastoiditis in the region Grand-Est of France between 2014 and 2024
The primary outcome was recovery by Day 5, i.e., recovery on the fifth day of hospitalization. Recovery was a composite outcome based on three subcriteria: * (i) absence of fever (body temperature ≥ 38°C); * AND (ii) absence of neutrophilia (neutrophil count \> 8.5 G/L); * AND (iii) absence of local symptoms (i.e., otalgia or ear inflammation). Patients presenting with fever OR neutrophilia OR local clinical symptoms on Day 5 or later were classified as not recovered by Day 5. Fever and local symptoms are monitored by the nursing staff several times a day during the hospitalization. The neutrophil count is measured as part of the laboratory test, performed on the day of hospital admission, and carried out multiple times during hospitalizations. The absence of follow-up laboratory testing suggests clinical improvement. The abovementioned outcomes were extracted, as well as variables known or suspected to be associated with mastoiditis recovery or complications.
From January 2014 to July 2024
Secondary Outcomes (2)
Evolution of complication rate of mastoiditis between January 2014 and July 2024
From January 2014 to July 2024
Factors associated with complicated acute mastoïditis
From January 2014 to July 2024
Interventions
retrospective data collection from clinical charts
Eligibility Criteria
Cf Eligibility criteria
You may qualify if:
- All patients under 15 years of age
- Supported in one of the ENT or pediatric services of the four investigation centers
- Between January 1, 2014 and July 31, 2024
- With a diagnosis of acute mastoiditis
You may not qualify if:
- Patient with history of cholesteatoma or cochlear implantation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cécile RUMEAUlead
Study Sites (1)
University Hospital Center of Nancy
Vandœuvre-lès-Nancy, 54500, France
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Head of Otolaryngology
Study Record Dates
First Submitted
January 3, 2024
First Posted
August 14, 2025
Study Start
March 2, 2024
Primary Completion
July 31, 2025
Study Completion
July 31, 2025
Last Updated
August 14, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share